A lease has been secured for 7,497 sq. ft. of fully fitted space within the Innovation Quarter (“IQ”) at Oxford Technology Park (“OTP”) to Coldquanta UK Limited (“ColdQuanta”), part of Infleqtion, a global quantum technology company. The lease will complete once the laboratory fitout works are complete.
ColdQuanta uses atomic physics to build quantum computers and to integrate them across networks, delivering an ecosystem of devices and platforms. This next generation of computing power has the potential to transform the life science industry by significantly reducing drug development time and costs and demonstrates the growing interdependence between technology and life sciences.
The IQ is a differentiated offer providing smaller, more flexible space at OTP. Covering 69,700 sq. ft., the IQ reached practical completion in August last year; it is EPC A rated and is on track to achieve a BREEAM Excellent certification.
Ian Harris, Director of Asset Management at Life Science REIT, said:
“We are really encouraged by the leasing momentum we are seeing at the IQ, strengthening our conviction in this more flexible format and the fully fitted proposition. The IQ also provides emerging life sciences businesses with the opportunity to grow and collaborate with like-minded businesses at OTP, in neighbouring Begbroke and the academic institutions in Oxford.”
OTP was acquired by Life Science REIT in May 2022. It now comprises six completed buildings totalling 231,600 sq. ft. and 266,100 sq. ft. of development space. Existing occupiers at the park include The Native Antigen Company, a developer and manufacturer of antigens and antibodies, Oxford Gene Technology, a provider of clinical research and diagnostic solutions, and Oxford Ionics, a leading quantum computing business.
To become apart of the OTP community and for more information about the available space at Oxford Technology Park, visit the website.
To book a viewing, contact the Agents:
Duncan May, Bidwells – M: 07879 883886, [email protected]
Christian Vecchione, Benedicts – 01865 883364, [email protected]
